SARS-CoV-2 Spike Protein and Long COVID—Part 1: Impact of Spike Protein in Pathophysiological Mechanisms of Long COVID Syndrome
Viruses · 2025
DOI: 10.3390/v17050617 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Viruses, 2025. Verfasst von Bruno Pereira de Melo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Neurovirology, Department of Pharmacy, Faculty of Health Science, University of Brasília, Brasilia 70910-900, DF, Brazil. Hauptthemen laut MEDLINE: Spike Glycoprotein, Coronavirus, COVID-19, SARS-CoV-2. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 162 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
SARS-CoV-2 infection has resulted in more than 700 million cases and nearly 7 million deaths worldwide. Although vaccination efforts have effectively reduced mortality and transmission rates, a significant proportion of recovered patients—up to 40%—develop long COVID syndrome (LC) or post-acute sequelae of COVID-19 infection (PASC). LC is characterized by the persistence or emergence of new symptoms following initial SARS-CoV-2 infection, affecting the cardiovascular, neurological, respiratory, gastrointestinal, reproductive, and immune systems. Despite the broad range of clinical symptoms that have been described, the risk factors and pathogenic mechanisms behind LC remain unclear. This review, the first of a two-part series, is distinguished by the discussion of the role of the SARS-CoV-2 spike protein in the primary mechanisms underlying the pathophysiology of LC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Molecular Neurovirology, Department of Pharmacy, Faculty of Health Science, University of Brasília, Brasilia 70910-900, DF, Brazil.
- Laboratory of Hematology and Stem Cells (LHCT), Faculty of Health Sciences, University of Brasília, Brasilia 70910-900, DF, Brazil.
ORCID-Profile: Bruno Pereira de Melo, Jhéssica Adriane Mello da Silva, Mariana Alves Rodrigues, Julys da Fonseca Palmeira, Felipe Saldanha-Araujo, Gustavo Adolfo Argañaraz, Enrique Roberto Argañaraz
Zitieren
APA
de Melo, B. P., da Silva, J. A. M., Rodrigues, M. A., Palmeira, J. D. F., Saldanha-Araujo, F., Argañaraz, G. A., & Argañaraz, E. R. (2025). SARS-CoV-2 Spike Protein and Long COVID—Part 1: Impact of Spike Protein in Pathophysiological Mechanisms of Long COVID Syndrome. Viruses. https://doi.org/10.3390/v17050617
Vancouver
de Melo BP, da Silva JAM, Rodrigues MA, Palmeira JDF, Saldanha-Araujo F, Argañaraz GA, et al. SARS-CoV-2 Spike Protein and Long COVID—Part 1: Impact of Spike Protein in Pathophysiological Mechanisms of Long COVID Syndrome. Viruses. 2025. doi:10.3390/v17050617
BibTeX
@article{deMelo2025,
author = {de Melo, Bruno Pereira and da Silva, Jhéssica Adriane Mello and Rodrigues, Mariana Alves and Palmeira, Julys da Fonseca and Saldanha-Araujo, Felipe and Argañaraz, Gustavo Adolfo and Argañaraz, Enrique Roberto},
title = {SARS-CoV-2 Spike Protein and Long COVID—Part 1: Impact of Spike Protein in Pathophysiological Mechanisms of Long COVID Syndrome},
journal = {Viruses},
year = {2025},
doi = {10.3390/v17050617}
}
EUVIMED